Literature DB >> 15106785

Worldwide prevalence of hypertension: a systematic review.

Patricia M Kearney1, Megan Whelton, Kristi Reynolds, Paul K Whelton, Jiang He.   

Abstract

PURPOSE: To examine the prevalence and the level of awareness, treatment and control of hypertension in different world regions. STUDY SELECTION: A literature search of the MEDLINE database, using the Medical Subject Headings prevalence, hypertension, blood pressure and cross-sectional studies, was conducted. Published studies, which reported the prevalence of hypertension and were conducted in representative population samples, were included in the review. The search was restricted to studies published from January 1980 through July 2003. DATA EXTRACTION: All data were extracted independently by two investigators using a standardized protocol and data collection form.
RESULTS: The reported prevalence of hypertension varied around the world, with the lowest prevalence in rural India (3.4% in men and 6.8% in women) and the highest prevalence in Poland (68.9% in men and 72.5% in women). Awareness of hypertension was reported for 46% of the studies and varied from 25.2% in Korea to 75% in Barbados; treatment varied from 10.7% in Mexico to 66% in Barbados and control (blood pressure < 140/90 mmHg while on antihypertensive medication) varied from 5.4% in Korea to 58% in Barbados.
CONCLUSION: Hypertension is an important public health challenge in both economically developing and developed countries. Significant numbers of individuals with hypertension are unaware of their condition and, among those with diagnosed hypertension, treatment is frequently inadequate. Measures are required at a population level to prevent the development of hypertension and to improve awareness, treatment and control of hypertension in the community.

Entities:  

Mesh:

Year:  2004        PMID: 15106785     DOI: 10.1097/00004872-200401000-00003

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  292 in total

1.  Prehypertension in young females, where do they stand?

Authors:  Kavita Chaudhry; Sanjay Kumar Diwan; S N Mahajan
Journal:  Indian Heart J       Date:  2012 May-Jun

2.  2011 Canadian Hypertension Education Program recommendations: an annual update.

Authors:  Norm Campbell
Journal:  Can Fam Physician       Date:  2011-12       Impact factor: 3.275

3.  Sugar-sweetened beverage taxes in Brazil.

Authors:  Rafael M Claro; Renata B Levy; Barry M Popkin; Carlos A Monteiro
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

4.  Canadian efforts to prevent and control hypertension.

Authors:  Norman R C Campbell; Guanmin Chen
Journal:  Can J Cardiol       Date:  2010 Aug-Sep       Impact factor: 5.223

5.  2010 Canadian Hypertension Education Program recommendations: An annual update.

Authors:  Norm Campbell; Margaret Moy Lum Kwong
Journal:  Can Fam Physician       Date:  2010-07       Impact factor: 3.275

6.  Hypertension in Pakistan: time to take some serious action.

Authors:  Fahad Saleem; Jalan Sungai Dua; Azmi Ahmad Hassali; Asrul Akmal Shafie
Journal:  Br J Gen Pract       Date:  2010-06       Impact factor: 5.386

7.  Does global obesity represent a global public health challenge?

Authors:  Barry M Popkin
Journal:  Am J Clin Nutr       Date:  2010-12-15       Impact factor: 7.045

Review 8.  Epidemiology of hypertensive kidney disease.

Authors:  Suneel Udani; Ivana Lazich; George L Bakris
Journal:  Nat Rev Nephrol       Date:  2010-11-16       Impact factor: 28.314

Review 9.  Apparent and true resistant hypertension: definition, prevalence and outcomes.

Authors:  E Judd; D A Calhoun
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

10.  Investigation of relationship between IL-6 gene variants and hypertension in Turkish population.

Authors:  Esin Karaman; Meral Urhan Kucuk; Aysegul Bayramoglu; Semire Uzun Göçmen; Süleyman Ercan; Halil Ibrahim Guler; Yunus Kucukkaya; Sema Erden
Journal:  Cytotechnology       Date:  2014-05-09       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.